| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 43.051 | 35.802 | 37.854 | 30.710 | 34.858 | 22.807 | 17.486 | 36.170 | 50.041 | 60.775 |
| Total Income - EUR | 43.051 | 35.803 | 37.854 | 30.710 | 34.858 | 22.807 | 17.486 | 36.170 | 50.041 | 60.776 |
| Total Expenses - EUR | 9.400 | 11.249 | 7.618 | 7.524 | 7.594 | 5.763 | 8.156 | 7.474 | 18.513 | 27.048 |
| Gross Profit/Loss - EUR | 33.651 | 24.554 | 30.236 | 23.186 | 27.264 | 17.045 | 9.330 | 28.696 | 31.528 | 33.728 |
| Net Profit/Loss - EUR | 32.714 | 23.890 | 29.100 | 22.265 | 26.218 | 16.393 | 9.130 | 27.839 | 31.028 | 32.792 |
| Employees | 1 | 3 | 2 | 2 | 2 | 2 | 3 | 2 | 2 | 2 |
Check the financial reports for the company - Isomed S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 104.963 | 104.569 | 80.021 | 43.663 | 47.013 | 61.989 | 53.272 | 61.482 | 45.891 | 40.778 |
| Inventories | 978 | 968 | 951 | 934 | 916 | 898 | 878 | 4.815 | 878 | 4.774 |
| Receivables | 31.391 | 24.295 | 22.879 | 21.631 | 21.941 | 20.397 | 26.480 | 21.351 | 26.179 | 23.943 |
| Cash | 72.595 | 79.307 | 56.191 | 21.098 | 24.156 | 40.694 | 25.914 | 35.316 | 18.834 | 12.061 |
| Shareholders Funds | 82.372 | 73.042 | 77.420 | 42.299 | 45.865 | 61.388 | 51.070 | 59.857 | 44.904 | 37.115 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 22.591 | 31.528 | 2.601 | 1.364 | 1.148 | 601 | 2.203 | 1.626 | 988 | 3.663 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8559 - 8559" | |||||||||
| CAEN Financial Year |
8559
|
|||||||||
Comments - Isomed S.r.l.